A Randomized, Open-Label Study of the Effect of Replacing CNI With Sirolimus in a Standard Care Regimen of CNI, CellCept, and Steroids on Renal Function in Heart Transplant Patients
Phase of Trial: Phase IV
Latest Information Update: 25 Jul 2016
At a glance
- Drugs Calcineurin inhibitors; Sirolimus
- Indications Heart transplant rejection
- Focus Therapeutic Use
- Acronyms STN
- Sponsors Roche
- 25 Apr 2007 Results have been reported.
- 04 Sep 2006 Status change
- 26 Nov 2005 New trial record.